definiens: shall mean all reasonable costs necessary to shut down, tenninate or dispose of Development, manufacturing or Commercialization activities or related contracts or materials following the tennination of this Agreement that the non - tenninating Party or non - breaching Party, as the case may be, does not want to continue or use, to the extent such activities, contracts and materials are included in the then current Annual WorkplanlBudget or Annual Commercialization PlanlBudget or have been otherwise approved by the JPT, JCT or JSC 1.87 Additional Definitions~ Each of the foHowing definitions is found in the body of this Agreement as indicated : If AMA GuidelinesAnnual Commercialization Plan / BudgetU I!Contract Sales Organization!t HDevelopment Cost Project AccountDistribution ActivitiesExcluded IndicationFunctional CurrencyLicense AgreementLicensing PartyLine Termination DateLosses " -16 - Section 5.4(e ) S.4(e ) 5 . 1 ( c ) 7.2 4.8 7.3 5 . 1 ( c ) 3.3 10.1 5 . 1 ( d ) Exhibit A 5.1(b ) 4.6(b ) 5.6 4.7(a ) Exhibit A l4.2(d ) 14.2(d ) 6.4(a ) 15.1(a ) .. CONFIDENTIAL TREATMENT REQUESTED Other Out - of - Pocket CostsOutside the Scope Inventions ARTICLE 2 SCOPE OF THE COLLABORATION 2.1 Purpose Section 4.8 Exhibit A Exhibit A 11 . 1 ( b ) 5.4(e ) 5.4(e ) 3.2 Exhibit A Exhibit A 14.1 4.8 9.1 Pursuant to the tenns of this Agreement, within the Field and the Territory, the Parties agree to ( a ) engage in Development activities with the goal of obtaining Regulatory Approval for Licensed Products, as soon as reasonably practicable, in one or more Commercially Significant Indications in each Major Market Country where it makes commercial sense to do so given the size of the potential market and the safety . and efficacy profile of each Licensed Product, ( b ) engage in Development activities with the goal of obtaining Regulatory Approval for Licensed Products, as soon as reasonably practicable, . to the tenns of this I~~~~I~ psoriasis Commercialization of such Licensed rrCIQUCts